中国人民保险集团股份有限公司 第四届董事会第二十六次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完 整性承担法律责任。 本公司第四届董事会第二十六次会议（以下简称"会议"）以书 面传签方式召开，会议通知和材料于 2024 年 5 月 21 日以书面方式通 知全体董事，会议表决截止日为 2024 年 5 月 28 日。会议的召开和参 加表决人数符合《中华人民共和国公司法》等相关法律、行政法规、 部门规章和《中国人民保险集团股份有限公司章程》的规定，会议合 法、有效。 经与会董事审议并表决，形成以下会议决议： 证券代码：601319 证券简称： 中国人保 公告编号：临 2024-017 一、审议通过了《关于聘请集团公司2024年度会计师事务所的议 案》，并同意提交股东大会审议 本议案已经审计委员会事前审议通过。 表决结果：13 票同意，0 票反对，0 票弃权 中国人民保险集团股份有限公司董事会 二、审议通过了《关于集团资本规划（2024-2026 年）的议案》， 并同意提交股东大会审议 表决结果：14 票同意，0 票反对，0 票弃权 ...

证券代码：601319 证券简称：中国人保 公告编号：临 2024-018 中国人民保险集团股份有限公司 关于变更会计师事务所的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 中国人民保险集团股份有限公司（以下简称"公司"或"本公司"） 于 2024 年 5 月 21 日至 2024 年 5 月 28 日以书面传签方式召开了第四 届董事会第二十六次会议，会议审议通过了《关于聘请集团公司 2024 年度会计师事务所的议案》，公司拟聘任安永华明会计师事务所（特 拟聘任的会计师事务所名称：安永华明会计师事务所（特殊普通 合伙）及安永会计师事务所 原聘任的会计师事务所名称：普华永道中天会计师事务所（特殊 普通合伙）及罗兵咸永道会计师事务所 变更会计师事务所的简要原因及前任会计师的异议情况：综合考 虑公司对审计服务的需求，根据会计师事务所选聘相关规定，经 履行招标程序并根据评标结果，公司拟聘任安永华明会计师事务 所（特殊普通合伙）及安永会计师事务所为 2024 年度财务报表及 内部控制审计机构。公司就变更会计师事务所相关事项与原 ...

第 1 頁 共 2 頁 v 1.1.1 EF001 免責聲明 | 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因 | | | --- | --- | | 公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 | | | 股票發行人現金股息公告 | | | 發行人名稱 | 中國人民保險集團股份有限公司 | | 股份代號 | 01339 | | 多櫃檯股份代號及貨幣 | 不適用 | | 相關股份代號及名稱 | 不適用 | | 公告標題 | 截至2023年12月31日止年度之末期股息(更新) | | 公告日期 | 2024年5月30日 | | 公告狀態 | 更新公告 | | 更新/撤回理由 | 更新股東批准日期、香港過戶登記處相關信息及代扣所得稅信息 | | 股息信息 | | | 股息類型 | 末期 | | 股息性質 | 普通股息 | | 財政年末 | 2023年12月31日 | | 宣派股息的報告期末 | 2023年12月31日 | | 宣派股息 | 每 股 0.156 RMB | | 股東批准日期 | 202 ...

证券代码：601319 证券简称：中国人保 公告编号：临 2024-016 中国人民保险集团股份有限公司 原保险保费收入公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 中国人民保险集团股份有限公司（"本公司"）2024 年 1 月 1 日至 2024 年 4 月 30 日经由本公司子公司中国人民财产保险股份有限 公司、中国人民人寿保险股份有限公司及中国人民健康保险股份有限 公司所获得的原保险保费收入分别为人民币 210,495 百万元、人民币 60,470 百万元及人民币 29,152 百万元。 中国人民财产保险股份有限公司上述期间原保险保费收入分类 明细如下： | | 单位：人民币百万元，百分比除外 | | | --- | --- | --- | | | 2024年1-4月 | 同比（%） | | 机动车辆险 | 91,082 | 2.3 | | 意外伤害及健康险 | 62,777 | 4.9 | | 农险 | 23,426 | 0.6 | | 责任险 | 14,002 | 0.9 | | 企业财产险 | 7,119 ...

Investment Rating - The investment rating for the company is "Buy" and is maintained [7]. Core Views - The company reported a net profit of 8.96 billion yuan for Q1 2024, a decrease of 23.5% year-on-year, primarily due to market volatility affecting investment income, which declined by approximately 39.4% [6][10]. - The combined cost ratio for the property and casualty insurance segment increased by 2.2 percentage points to 97.9% due to natural disasters and increased travel rates [6]. - The new business value for life insurance grew significantly by 81.6% year-on-year, indicating strong performance in this segment despite a decline in new single premium income [6][10]. Summary by Sections Financial Performance - The company achieved a net profit of 8.96 billion yuan in Q1 2024, down 23.5% year-on-year [6]. - The property and casualty insurance segment reported premium income of 173.98 billion yuan, up 3.8% year-on-year, with auto insurance premiums at 69.24 billion yuan, a 1.9% increase [6]. - The life insurance segment saw new single premium income of 24.3 billion yuan, a decrease of 21.4% year-on-year, but the new business value increased significantly [6]. Business Segments - The property and casualty insurance segment's profitability was impacted by natural disasters, with a combined cost ratio of 97.9% [6]. - The life insurance segment showed a notable improvement in quality, with a new business value growth of 81.6% year-on-year, driven by better pricing and product offerings [6][10]. - Health insurance also performed well, with new single premium income growing by 48.1% year-on-year [6]. Market Outlook - Despite short-term pressures from natural disasters and market volatility, the company's fundamental strength and profitability remain intact [6]. - The report anticipates improvements in both underwriting profits and investment income, supported by enhanced regulatory oversight leading to increased industry concentration in the long term [6].

Investment Rating - The report maintains a "Buy" rating for China People's Insurance Group with a target price of HKD 3.99, based on the company's competitive advantages in property insurance and significant improvements in life and health insurance value rates [6][5]. Core Insights - The company reported an insurance service revenue of CNY 126.17 billion for Q1 2024, a year-on-year increase of 7.7%, while the net profit attributable to shareholders was CNY 8.96 billion, down 23.5% year-on-year [2][5]. - The property insurance segment showed a slight increase in premium income, with a year-on-year growth of 3.8% to CNY 173.98 billion, although the growth rate was slightly below the industry average [3]. - The life insurance segment experienced a significant increase in new business value (NBV), up 81.6% year-on-year, driven by a low base and improved value rate [4]. - The health insurance segment also performed well, with a net profit of CNY 1.52 billion, reflecting a year-on-year increase of 48.7% [4]. Financial Performance Summary - The total investment income for Q1 2024 was estimated at CNY 11.9 billion, a decrease of 39.1% year-on-year, primarily due to increased market volatility affecting investment returns [5]. - The report forecasts net profits for 2024, 2025, and 2026 to be CNY 28.41 billion, CNY 32.00 billion, and CNY 34.89 billion respectively, with growth rates of 27%, 13%, and 9% [5][6]. - The company's total assets are projected to grow from CNY 1.70 trillion in 2024 to CNY 1.83 trillion by 2026, indicating a steady growth trajectory [10].

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2024年4月30日 狀態: 新提交 致：香港交易及結算所有限公司 | 2. 股份分類 | 普通股 | 股份類別 A | | | | 於香港聯交所上市 (註1) | | 否 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 | 601319 | 說明 | | 於上海證券交易所上市 | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 35,497,756,583 | RMB | | 1 | RMB | | 35,497,756,583 | | 增加 / 減少 (-) | | | 0 | | | | RMB | | 0 | | 本月底結存 | | | 35,497,756,583 | RMB | | 1 | RMB | | 35,497,756,583 | 本月底法定/註冊股本總額： RMB 44,223,990,583 備註： 第 1 頁 共 ...

2024年4月30日 公司研究 财产险 COR 优于同业，人身险 NBV 同比高增 ——中国人保（601319.SH）、中国人民保险集团（1339.HK）2024 年一季报点评 A 股：买入（维持） 要点 当前价：5.25元人民币 H 股：买入（维持） 事件： 2024年一季度，中国人保营业收入1387.8亿元，同比+0.7%；归母净利润89.6 当前价：2.58港币 亿元，同比-23.5%；加权平均净资产收益率 3.7%，同比-1.3pct；综合成本率 97.9%，同比+2.2pct；人保寿险新业务价值同比+81.6%。 作者 分析师：王一峰 执业证书编号：S0930519050002 点评： 010-57378038 wangyf@ebscn.com 财产险：业务结构持续优化，COR同比抬升但仍优于主要上市同业。 联系人：黄怡婷 1）2024年一季度，公司实现财产险保费收入1739.8亿元，同比+3.8%，其中车 010-57378023 huangyiting@ebscn.com 险保费收入692.4亿元，同比+1.9%，非车险保费收入1047.4亿元，同比+5.0%， 市场数据（A股） 主要受益于意健 ...

[Table_MainInfo] 公司研究/金融/保险 证券研究报告 中国人保（601319）公司季报点评 2024年05月01日 [Table_InvestInfo] 综合成本率同比有所提高，寿险 NBV 实现 投资评级 优于大市 维持 大幅增长 股票数据 [0T4a月ble30_日St收oc盘k价In（fo元] ） 5.25 [Table_Summary] 52周股价波动（元） 4.52-6.95 投资要点： 股本结构 [总Ta股b本le（_C百a万p股ita）lI nfo] 44224 流通A股（百万股） 35497.756583  【事件】中国人保发布 2024 年一季度业绩：1）归母净利润 89.6 亿元，同比 -23.5%，财险/寿险/健康险净利润分别为 58.7 亿元、38.2 亿元、15.2 亿元，分 B股/H股（百万股） 0/8726 别同比-40.2%、+28.0%、+48.7%。2）归母净资产2458亿元，较年初+1.4%。 相关研究 [《Ta财b险le C_R ORep表o现rtI依nf然o稳] 健，人身险NBV  产险：自然灾害等因素导致综合成本率同比提高。1）Q1产险总保费收入 ...

Investment Rating - The report maintains a "Recommend" rating for the company with a target price of 7.1 yuan [2][3]. Core Insights - The company reported a 7.7% year-on-year increase in insurance service revenue for Q1 2024, totaling 126.2 billion yuan, while the net profit attributable to shareholders decreased by 23.5% year-on-year to 9 billion yuan [2][3]. - The weighted average ROE was 3.7%, down 1.3 percentage points year-on-year [2]. - The combined ratio (COR) for property insurance reached 97.9%, an increase of 2.2 percentage points year-on-year, but still better than peers [3]. - The new business value (NBV) for life insurance saw a remarkable increase of 81.6% year-on-year, despite a decline in original premiums by 8.2% to 54.5 billion yuan [3]. Financial Performance Summary - For Q1 2024, the property insurance segment generated 113.8 billion yuan in insurance service revenue, reflecting a 5.9% year-on-year growth [3]. - The market share for property insurance reached 35.5%, with a growth rate of 3.8% in original premiums, placing it in the middle among major listed insurers [3]. - The life insurance segment's original premiums decreased, with first-year long-term insurance premiums down 21.4% to 24.3 billion yuan, but the new business value significantly increased due to improved pricing rates and cost reductions [3]. - Investment income was adversely affected by market fluctuations, leading to a 69.1% year-on-year decrease in investment income, totaling a reduction of 5.6 billion yuan [3]. Future Outlook - The company is expected to maintain its leadership in property insurance, supported by a 1/3 market share and improved risk management, driving underwriting profitability [3]. - Despite regulatory pressures and high base effects from the previous year impacting life insurance growth, the new business value rate is anticipated to continue compensating for the slowdown in new policy growth [3]. - The health insurance segment is projected to perform well due to increasing demand in healthcare and elderly care, with a 40.6% year-on-year increase in insurance service revenue [3].